Pierre Fabre: all 145 studies

Page 1 of 2. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.

• Comparison Between Different Interdental Brushes in Adults With Periodontal Disease.RecruitingNCT07575997Not applicable
• Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 WeeksRecruitingNCT07014007Not applicable
• A Comparative Study of Cosmetic Product in Subjects With Facial Acne During an Associated-treatment Phase Followed by a Maintenance PhaseRecruitingNCT06716398Not applicable
• FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET AlterationsRecruitingNCT06669117Phase 1/2
• Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIsRecruitingNCT06567015Phase 1/2
• First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion MutationsRecruitingNCT06043817Phase 1/2
• Treatment Patterns of Neratinib in HER2+ EBC in ChinaNot yet recruitingNCT05491057
• A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid TumorsRecruitingNCT04913285Phase 1
• BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC TreatmentRecruitingNCT04673955
• Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma TreatmentRecruitingNCT04045691
• A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and ChemotherapyRecruitingNCT03394365Phase 3
• The Performance and Safety of Petit Drill in the French Paediatric Population: a Post-market Clinical Follow-up StudyTerminatedNCT06688370Results posted
• Study on Structum® in Adult Patients With Osteoarthritis (TRUST)CompletedNCT06623773Results posted
• Bioequivalence Binimetinib 3 x 15 mg and 45 mg FormulationsCompletedNCT05810740Phase 1Results posted
• A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With NeratinibCompletedNCT05599334Results posted
• A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer.CompletedNCT05004350Phase 2Results posted
• Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant Solid TumorsCompletedNCT05003622Phase 1Results posted
• A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)CompletedNCT04317599Results posted
• Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Metastatic Breast CancerCompletedNCT03887130Phase 2Results posted
• Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal CancerCompletedNCT03693170Phase 2Results posted
• Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck CancerCompletedNCT02347332Phase 3Results posted
• A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast CancerTerminatedNCT02054338Phase 3Results posted
• Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerCompletedNCT01953003Phase 3Results posted
• Efficacy and Safety Study of F373280CompletedNCT01831856Phase 2Results posted
• Trial of Vinflunine Plus Capecitabine in Advanced Breast CancerCompletedNCT01095003Phase 3Results posted
• Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast CancerCompletedNCT01091168Phase 3Results posted
• Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic TherapyCompletedNCT01056341Phase 2/3Results posted
• EFFICACY AND TOLERANCE OF AN EMOLLIENT CREAM IN SKIN OF COLORCompletedNCT07839897Not applicable
• EFFICACY AND TOLERANCE OF AN EYELID BALM IN COMBINATION WITH TACROLIMUS 0.1% IN PATIENTS WITH EYELID ATOPIC DERMATITISCompletedNCT07819071Not applicable
• A Randomized, Comparative Study to Evaluate the Effect of RL3014A-DP0421 Mouthwash on the Oral Microbial CompositionCompletedNCT07685782Not applicable
• Evaluation of the Efficacy of a Cosmetic Care in Subjects With Moderate to Severe Atopic Dermatitis, Treated by Systemic TreatmentsCompletedNCT07577921
• A 4-weeks Comparative Study of Cosmetic Product Versus Standard Medical Care in Subjects With Seborrheic DermatitisCompletedNCT07576023Not applicable
• Efficacy of Cosmetic Product RV3278B-OS0386 in the Maintenance Phase After Oral Isotretinoin Treatment of Adults Subjects With Facial Acne.Active, not recruitingNCT07341659Not applicable
• Evaluation of the Moisturizing Effect of Study Product AV0018B and the Persistence of This Effect After Repeated Applications, Compared to an Untreated Control Area.CompletedNCT07271628
• In-use Tolerance and Efficacy Study Under Dermatological and Ophthalmological Controls - Face Cream, RV4983A - LA3365CompletedNCT07208227
• In-Use Tolerance & Efficacy Study Under Dermatological Control of Sunscreen in Adults With Atopic Dermatitis SkinCompletedNCT07194421
• In-Use Tolerance Study Under Dermatological and Pediatric Controls of Sunscreen in Children With Atopic DermatitisCompletedNCT07194408
• Evaluation of the Effect of the Product RV4660C CY0203 on Clinical, Biometrological and Biological Parameters in Adults With Mild to Moderate Atopic Dermatitis, an Exploratory StudyCompletedNCT07166497
• Assessment of the Effect of the Product RV2666C Formula LA2984 Compared to an Untreated Area With an Epidermally Ablated Skin Model Obtained With an Erbium YAG Laser on Adults Presenting IV to VI Skin PhototypeCompletedNCT07166484
• A 6-months Observational Study to Evaluate the Quality of Life of Patients Treated With Phytotherapy or Alpha-blockers for Benign Prostatic HyperplasiaCompletedNCT07144709
• Characteristics and Impacts of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) in Boys: An Observational International StudyCompletedNCT07096206
• UK ENcorafenib and BInimetinib Real-world Study in MelanomaActive, not recruitingNCT07022457
• Exploratory Study to Evaluate the Efficacy of the Cosmetic Product RV3895A on Re-epidermised Scars Following Burns and Surgical Stitches in Adults, Adolescents and Children Over a 6-month Follow-up PeriodTerminatedNCT07020507
• Assessment of Clinical, Biological and Biometrological Parameters in Adults Subjects With Atopic DermatitisCompletedNCT07017348Not applicable
• Evaluation of the Effects of the Product RV5075A-MF6793 in Diabetic Patients Presenting Foot Xerosis and Superficial Fissures, an Exploratory Study.CompletedNCT06997718Not applicable
• Description of the Population With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments and Needs Regarding EmollientsCompletedNCT06983561
• In-use Tolerance and Efficacy Study Under Dermatological Control of an Anti-aging Cream (Split Face) Post Facial Superficial Rejuvenation Procedures, After re EpidermizationCompletedNCT06942403Not applicable
• Assessment of Biological and Biometrological Parameters in Adult Subjects with Androgenetic AlopeciaTerminatedNCT06854432Not applicable
• Assessment of Biological, Biometrological Parameters and Consumer Needs in Adult Subjects with AcneTerminatedNCT06841393Not applicable
• Exploratory Study Evaluating the Effects of Dermo-cosmetic RV5026B Applied for 2 Months in Adults With ErythrocouperosisTerminatedNCT06824870Not applicable
• Evaluation of the Efficacy and Tolerance of the Medical Device RL3020-DP0364 in Adult Population With Stable Mild Plaque Psoriasis, Dry Skin and PruritusCompletedNCT06800755Not applicable
• Evaluation of the Efficacy of a Dermocosmetic Product RT00401-GO0046 on Atopic Dermititis Severity in Subjects With Mild Atopic Dermatitis Versus PlaceboCompletedNCT06763939
• An Observational Real-world Study to Evaluate the Impact of Dermatological Toxicities on the Quality of Life in Patients With Early Breast Cancer Treated With Adjuvant Endocrine Therapy - BCARE (Breast Cancer Adjuvant Real-world Evaluation of Dermatological Adverse Events)CompletedNCT06690489
• Efficacy of Cosmetic Product RV3278B-OS0386 on Skin Surface Ecosystem, in Teenagers with Mild to Moderate Facial AcneCompletedNCT06659861Not applicable
• Efficacy of a Cosmetic Shampoo RV3438G in Reccurent Squamous StatesCompletedNCT06578962
• Assessment of the Effects and Tolerance of the RV4986A Lotion in Men With AGA After Hair TransplantCompletedNCT06576492Not applicable
• To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of TreatmentActive, not recruitingNCT06500494
• Efficacy & Tolerance of Cosmetic Product RV5098A on Face Pigmentation Maintenance in Adult Vitiligo Patients.TerminatedNCT06446063
• Biological Anti-aging Efficacy of a Cosmetic Night CreamCompletedNCT06433323
• Re-epithelialization Efficacy Evaluation of Cosmetic Product RV1551P vs Non-treated Forearm of Healthy Adult WomenCompletedNCT06387277
• Evaluation of the Tolerance of the Medical Device RL3010A - DP0378 in Children and Adults Presenting a Superficial Wound After a Dermatological ProcedureCompletedNCT06016803Not applicable
• Photoprotective Effects of a SPF50+ Sunscreen on Skin Genotoxicity Induced by Repeated Chronic Outdoor Sun ExposureCompletedNCT05926791
• Clinical and Biological Anti-aging Efficacy of a Cosmetic CreamCompletedNCT05895591Not applicable
• Determination of Product Thickness Applied on Different Areas of the Face Using a Multispectral Imaging MethodCompletedNCT05837208
• Evaluate the Efficacy and the Tolerance of the Medical Device V063B-DP3003 on Dentin Hypersensitivity During Teeth WhiteningCompletedNCT05804994Not applicable
• Assessment of a Cosmetic Product Effect on the Host/Microorganism Relationship in Acneic SubjectsCompletedNCT05640388
• Assessment of Clinical, Biological and Biometrological Paramaters in Adult Subjects Suffering From ADTerminatedNCT05639738Not applicable
• A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS)CompletedNCT05546905
• Prospective Real-World Clinical Investigation on Dexyane Med® in Adults With Chronic Hand EczemaWithdrawnNCT05545215
• Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.Active, not recruitingNCT05270044Phase 3
• Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung CancerActive, not recruitingNCT05195632Phase 2
• IN-USE TOLERANCE STUDY UNDER DERMATOLOGICAL AND OPHTHALMOLOGICAL CONTROLS AND EFFICACY ASSESSMENT (Face Balm)CompletedNCT05171556
• Sunscreen Efficacy Against the Reccurence of Lesions Post-sun Exposure in Acneic SubjectsCompletedNCT05168397
• IN-USE TOLERANCE STUDY UNDER DERMATOLOGICAL AND OPHTHALMOLOGICAL CONTROLS AND EFFICACY ASSESSMENT (Face Cream)CompletedNCT05165420
• Relative Bioavailability of Binimetinib 3 x 15 mg and 45 mg FormulationsStatus unknownNCT05103891Phase 1
• A Prospective Observational Study on Targeted Therapy for Unresectable or Metastatic BRAFV600E Mutant Melanoma PatientsCompletedNCT04911998
• Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical TrialCompletedNCT04875026Phase 4
• Efficacy Study of Cosmetic Product RV3278AET0943 Versus Non-treated Group in Adults With Oily and Acne Prone SkinCompletedNCT04873089
• Hepatic Impairment Study of Encorafenib in Combination With Binimetinib in BRAF MelanomaWithdrawnNCT04759846Phase 1
• Assessment of the Wound Healing Efficacy and Tolerance of a Medical Device on Wounds in Healthy Subjects.CompletedNCT04687839Not applicable
• Efficacy Study of Cosmetic Product Against Telogen Effluvium on WomenCompletedNCT04652232Not applicable
• First-In-Human (FIH) Study of W0180 as Single Agent and in Combination With Pembrolizumab in Adults With Locally Advanced or Metastatic Solid TumorsTerminatedNCT04564417Phase 1
• A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated DiseasesActive, not recruitingNCT04554914Phase 2
• Collection of Clinical and Instrumental Data in Adult Subjects Suffering From Atopic DermatitisCompletedNCT04553224Not applicable
• Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory DermatosisCompletedNCT04472546Not applicable
• Characterization and Functionality of Calcium Channels Cav1.4 of Th17 Lymphocytes in Human With PsoriasisCompletedNCT04459780Not applicable
• Real-life Pan-HER-blockade With NeratinibCompletedNCT04388384
• Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE).CompletedNCT04318405
• Assess the Effects and the Tolerance of Cosmetic Product in the Follow-up Phase of Facial Acne for 1 YearCompletedNCT04301063
• Demonstration of the Presence of a Carbonyl Stress in the Hair Follicles of Postpartum WomenCompletedNCT04237402Not applicable
• Efficacy Study of Cosmetic Product on Xerosis Induced by Systemic Anticancer TreatmentsCompletedNCT04181177
• Bioavailability Pilot Study of Versus W0035 Versus StromectolWithdrawnNCT03717558Phase 1
• Identification of Biomarkers and Characterization of MelasmaWithdrawnNCT03618277Not applicable
• Efficacy and Tolerance of D-pigment Versus Moisturizer in Hands' Lentigo Lesions With or Without Laser TherapyCompletedNCT03457246Not applicable
• Demonstration of Carbonyl Stress on Hair FolliclesCompletedNCT03414476Not applicable
• A Study of a New Investigational Medicinal Product to Treat Patients with Advanced or Metastatic Solid TumorsTerminatedNCT03316638Phase 1/2
• An Exploratory Study to Assess the Efficacy of the Avène HydrotherapyCompletedNCT03023254Not applicable
• EXPLORATORY ASSESSMENT OF THE EFFECTS OF CYCLO 3 ® FORT (Ruscus Extract, Hesperidin Methyl Chalcone, Ascorbic Acid) OR MICRONISED PURIFIED FLAVONOID FRACTION ON VASCULAR PARAMETERS AND BIOMARKERS IN WOMEN SUFFERING FROM CHRONIC VENOUS DISEASE (CEAP C2 OR C3), OVER 8 WEEKSWithdrawnNCT02907320Phase 2
• Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and AustriaCompletedNCT02619929
• Ferrous Sulphate Supplement (V0355) in Women With Iron Deficiency AnaemiaTerminatedNCT02518568Phase 1

← Pierre Fabre overview and focus areas